Avid Bioservices Inc (CDMO)

[biopharm]

More leverage for Peregrine Pharmaceuticals...

Besides the hopeful outlook for doubling of "MOS" of multiple cancer trials currently.... the successful partnership and/or buyout will still hinge on Peregrine finding and agreeing to a lucrative deal with a BP that doesn't have hidden agendas and of course to have politics on their side and its trending that way as well as many BP's are being watched by the FTC on some of the secret deals they make to keep competitors drugs at bay for a little longer

http://ycharts.com/analysis/story/big_pharma_gains_another_foe_on_paytodelay_deals_31_state_ags_file_supreme_court_brief


"Yet another group is speaking out against so-called pay-to-delay deals between brand-name and generic drugmakers. A group of 31 state attorneys general has filed a friend-of-the-court brief supporting a recent request by the US Federal Trade Commission to have the US Supreme Court review these controversial agreements."

I believe politically there is soo much attention on the health care budget and big pharma that its going to be very difficult for a BP that has a drug on the market to stop the entrance of competing drugs. This snow ball effect will surely help Peregrine because we are not talking about just cancer drugs... this effects any drug which eventually decreases a BP's profits all around and they need to find new ways to boost revenues and I see this as a big boost for Peregrine because one of the many BP's will want to jump on the Bavi pipeline before its too late and IMHO we will have a partner/buyout sooner than later.

----------------------